Envela Corp — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Envela Corp filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $241.02M | Mar 18, 2026 |
| FY2025 | Dec 31, 2024 | $180.38M | Mar 18, 2026 |
| FY2024 | Dec 31, 2023 | $37.48M | Mar 26, 2025 |
| FY2024 | Sep 30, 2023 | $36.88M | Mar 26, 2025 |
| FY2024 | Jun 30, 2023 | $51.10M | Mar 26, 2025 |
| FY2024 | Mar 31, 2023 | $49.81M | Mar 26, 2025 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $171.67M | Mar 21, 2024 |
| FY2023 | Dec 31, 2022 | $182.69M | Mar 21, 2024 |
| FY2022 | Dec 31, 2021 | $140.97M | Mar 16, 2023 |
| FY2022 | Dec 31, 2020 | $113.92M | Mar 16, 2022 |
| FY2020 | Dec 31, 2019 | $82.02M | Mar 26, 2021 |
| FY2019 | Dec 31, 2018 | $54.06M | Mar 26, 2020 |
| FY2018 | Dec 31, 2017 | $61.99M | Apr 12, 2019 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $61.99M | Mar 21, 2018 |
| FY2017 | Dec 31, 2016 | $48.33M | Mar 21, 2018 |
| FY2016 | Dec 31, 2015 | $60.92M | Apr 14, 2017 |
| FY2015 | Dec 31, 2014 | $70.74M | Mar 30, 2016 |
| FY2014 | Dec 31, 2013 | $87.10M | Mar 26, 2015 |
| FY2013 | Dec 31, 2012 | $127.88M | Mar 27, 2014 |
| FY2012 | Dec 31, 2011 | $139.16M | Mar 28, 2013 |
| FY2011 | Dec 31, 2010 | $82.57M | Dec 19, 2012 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $53.92M | Mar 18, 2026 |
| FY2025 | Dec 31, 2024 | $44.32M | Mar 18, 2026 |
| FY2024 | Dec 31, 2023 | $9.75M | Mar 26, 2025 |
| FY2024 | Sep 30, 2023 | $9.73M | Mar 26, 2025 |
| FY2024 | Jun 30, 2023 | $10.76M | Mar 26, 2025 |
| FY2024 | Mar 31, 2023 | $11.41M | Mar 26, 2025 |
| FY2023 | Dec 31, 2022 | $44.83M | Mar 21, 2024 |
| FY2022 | Dec 31, 2021 | $31.22M | Mar 16, 2023 |
| FY2022 | Dec 31, 2020 | $23.07M | Mar 16, 2022 |
| FY2020 | Dec 31, 2019 | $16.26M | Mar 26, 2021 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $14.60M | Mar 18, 2026 |
| FY2025 | Dec 31, 2024 | $6.76M | Mar 18, 2026 |
| FY2024 | Dec 31, 2023 | $7.15M | Mar 26, 2025 |
| FY2023 | Dec 31, 2022 | $15.69M | Mar 21, 2024 |
| FY2022 | Dec 31, 2021 | $10.05M | Mar 16, 2023 |
| FY2022 | Dec 31, 2020 | $6.38M | Mar 16, 2022 |
| FY2020 | Dec 31, 2019 | $2.78M | Mar 26, 2021 |
| FY2019 | Dec 31, 2018 | $657.7K | Mar 26, 2020 |
| FY2018 | Dec 31, 2017 | $1.84M | Apr 12, 2019 |
| FY2017 | Dec 31, 2016 | ($4.01M) | Mar 21, 2018 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $18.11M | Mar 18, 2026 |
| FY2025 | Dec 31, 2024 | $8.16M | Mar 18, 2026 |
| FY2024 | Dec 31, 2023 | $8.76M | Mar 26, 2025 |
| FY2023 | Dec 31, 2022 | $13.94M | Mar 21, 2024 |
| FY2022 | Dec 31, 2021 | $9.50M | Mar 16, 2023 |
| FY2022 | Dec 31, 2020 | $6.79M | Mar 16, 2022 |
| FY2020 | Dec 31, 2019 | $3.24M | Mar 26, 2021 |
| FY2019 | Dec 31, 2018 | $651.4K | Mar 26, 2020 |
| FY2018 | Dec 31, 2017 | $1.95M | Apr 12, 2019 |
| FY2017 | Dec 31, 2016 | ($3.60M) | Mar 21, 2018 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $33.95M | Mar 18, 2026 |
| FY2025 | Dec 31, 2024 | $34.61M | Mar 18, 2026 |
| FY2024 | Dec 31, 2023 | $31.54M | Mar 26, 2025 |
| FY2023 | Dec 31, 2022 | $29.43M | Mar 21, 2024 |
| FY2022 | Dec 31, 2021 | $20.80M | Mar 16, 2023 |
| FY2022 | Dec 31, 2020 | $15.55M | Mar 16, 2022 |
| FY2020 | Dec 31, 2019 | $12.49M | Mar 26, 2021 |
| FY2019 | Dec 31, 2018 | $8.70M | Mar 26, 2020 |
| FY2018 | Dec 31, 2017 | $8.98M | Apr 12, 2019 |
| FY2017 | Dec 31, 2016 | $10.35M | Mar 21, 2018 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.58M | Mar 18, 2026 |
| FY2025 | Dec 31, 2024 | $10.19M | Mar 18, 2026 |
| FY2024 | Dec 31, 2023 | $5.84M | Mar 26, 2025 |
| FY2023 | Dec 31, 2022 | $10.02M | Mar 21, 2024 |
| FY2022 | Dec 31, 2021 | $2.81M | Mar 16, 2023 |
| FY2022 | Dec 31, 2020 | $6.90M | Mar 16, 2022 |
| FY2020 | Dec 31, 2019 | ($542.8K) | Mar 26, 2021 |
| FY2019 | Dec 31, 2018 | $375.2K | Mar 26, 2020 |
| FY2018 | Dec 31, 2017 | $248.3K | Apr 12, 2019 |
| FY2017 | Dec 31, 2016 | $381.6K | Mar 21, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.20M | Mar 18, 2026 |
| FY2025 | Dec 31, 2024 | $3.46M | Mar 18, 2026 |
| FY2024 | Dec 31, 2023 | $2.05M | Mar 26, 2025 |
| FY2023 | Dec 31, 2022 | $272.7K | Mar 21, 2024 |
| FY2022 | Dec 31, 2021 | $3.14M | Mar 16, 2023 |
| FY2022 | Dec 31, 2020 | $5.86M | Mar 16, 2022 |
| FY2020 | Dec 31, 2019 | $103.0K | Mar 26, 2021 |
| FY2019 | Dec 31, 2018 | $125.1K | Mar 26, 2020 |
| FY2018 | Dec 31, 2017 | $376.8K | Apr 12, 2019 |
| FY2017 | Dec 31, 2016 | $1.18M | Mar 21, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $96.02M | Mar 18, 2026 |
| FY2025 | Dec 31, 2024 | $77.87M | Mar 18, 2026 |
| FY2024 | Dec 31, 2023 | $73.47M | Mar 26, 2025 |
| FY2023 | Dec 31, 2022 | $71.28M | Mar 21, 2024 |
| FY2022 | Dec 31, 2021 | $59.27M | Mar 16, 2023 |
| FY2020 | Dec 31, 2020 | $40.58M | Mar 26, 2021 |
| FY2020 | Dec 31, 2019 | $27.00M | Mar 26, 2021 |
| FY2019 | Dec 31, 2018 | $13.02M | Mar 26, 2020 |
| FY2018 | Dec 31, 2017 | $13.31M | Apr 12, 2019 |
| FY2017 | Dec 31, 2016 | $12.91M | Mar 21, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $28.96M | Mar 18, 2026 |
| FY2025 | Dec 31, 2024 | $25.22M | Mar 18, 2026 |
| FY2024 | Dec 31, 2023 | $25.17M | Mar 26, 2025 |
| FY2023 | Dec 31, 2022 | $27.96M | Mar 21, 2024 |
| FY2022 | Dec 31, 2021 | $31.64M | Mar 16, 2023 |
| FY2022 | Dec 31, 2020 | $23.00M | Mar 16, 2022 |
| FY2020 | Dec 31, 2019 | $15.81M | Mar 26, 2021 |
| FY2019 | Dec 31, 2018 | $4.60M | Mar 26, 2020 |
| FY2017 | Dec 31, 2017 | $5.56M | Mar 21, 2018 |
| FY2017 | Dec 31, 2016 | $7.01M | Mar 21, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $67.06M | Mar 18, 2026 |
| FY2025 | Dec 31, 2024 | $52.65M | Mar 18, 2026 |
| FY2025 | Dec 31, 2023 | $48.31M | Mar 18, 2026 |
| FY2024 | Dec 31, 2022 | $43.32M | Mar 26, 2025 |
| FY2023 | Dec 31, 2021 | $27.63M | Mar 21, 2024 |
| FY2022 | Dec 31, 2020 | $17.58M | Mar 16, 2023 |
| FY2022 | Dec 31, 2019 | $11.19M | Mar 16, 2022 |
| FY2020 | Dec 31, 2018 | $11.19M | Mar 26, 2021 |
| FY2019 | Dec 31, 2017 | $7.76M | Mar 26, 2020 |
| FY2018 | Dec 31, 2016 | $5.91M | Apr 12, 2019 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.62M | Mar 18, 2026 |
| FY2025 | Dec 31, 2024 | $3.62M | Mar 18, 2026 |
| FY2024 | Dec 31, 2023 | $3.92M | Mar 26, 2025 |
| FY2023 | Dec 31, 2022 | $3.62M | Mar 21, 2024 |
| FY2023 | Dec 31, 2021 | $6.14M | Mar 21, 2024 |
| FY2022 | Dec 31, 2020 | $1.37M | Mar 16, 2023 |
| FY2022 | Dec 31, 2019 | $1.37M | Mar 16, 2023 |
| FY2022 | Dec 31, 2018 | $0 | Mar 16, 2023 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $31.38M | Mar 18, 2026 |
| FY2025 | Dec 31, 2024 | $16.78M | Mar 18, 2026 |
| FY2024 | Dec 31, 2023 | $10.02M | Mar 26, 2025 |
| FY2023 | Dec 31, 2022 | $2.87M | Mar 21, 2024 |
| FY2022 | Dec 31, 2021 | ($12.81M) | Mar 16, 2023 |
| FY2022 | Dec 31, 2020 | ($22.86M) | Mar 16, 2022 |
| FY2020 | Dec 31, 2019 | ($29.25M) | Mar 26, 2021 |
| FY2019 | Dec 31, 2018 | ($32.03M) | Mar 26, 2020 |
| FY2018 | Dec 31, 2017 | ($32.69M) | Apr 12, 2019 |
| FY2017 | Dec 31, 2016 | ($34.52M) | Mar 21, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $17.85M | Mar 21, 2024 |
| FY2023 | Dec 31, 2022 | $17.17M | Mar 21, 2024 |
| FY2022 | Dec 31, 2021 | $10.14M | Mar 16, 2023 |
| FY2022 | Dec 31, 2020 | $9.22M | Mar 16, 2022 |
| FY2020 | Dec 31, 2019 | $4.51M | Mar 26, 2021 |
| FY2019 | Dec 31, 2018 | $1.45M | Mar 26, 2020 |
| FY2018 | Dec 31, 2017 | $1.27M | Apr 12, 2019 |
| FY2018 | Dec 31, 2016 | $1.41M | Apr 12, 2019 |
| FY2017 | Dec 31, 2015 | $1.75M | Mar 21, 2018 |
| FY2016 | Dec 31, 2014 | $2.18M | Apr 14, 2017 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $9.92M | Mar 18, 2026 |
| FY2025 | Dec 31, 2024 | $13.52M | Mar 18, 2026 |
| FY2024 | Dec 31, 2023 | $14.93M | Mar 26, 2025 |
| FY2023 | Dec 31, 2022 | $14.73M | Mar 21, 2024 |
| FY2022 | Dec 31, 2021 | $15.97M | Mar 16, 2023 |
| FY2022 | Dec 31, 2020 | $15.41M | Mar 16, 2022 |
| FY2020 | Dec 31, 2019 | $0 | Mar 26, 2021 |
| FY2017 | Dec 31, 2017 | $0 | Mar 21, 2018 |
| FY2017 | Dec 31, 2016 | $1.1K | Mar 21, 2018 |
| FY2016 | Dec 31, 2015 | $2.32M | Apr 14, 2017 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 18, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 18, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Mar 26, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Mar 21, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Mar 16, 2023 |
| FY2022 | Dec 31, 2020 | 0 | Mar 16, 2022 |
| FY2020 | Dec 31, 2019 | 0 | Mar 26, 2021 |
| FY2019 | Dec 31, 2018 | 0 | Mar 26, 2020 |
| FY2018 | Dec 31, 2017 | 0 | Apr 12, 2019 |
| FY2017 | Dec 31, 2016 | 0 | Mar 21, 2018 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 18, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 18, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Mar 26, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Mar 21, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Mar 16, 2023 |
| FY2022 | Dec 31, 2020 | 0 | Mar 16, 2022 |
| FY2020 | Dec 31, 2019 | 0 | Mar 26, 2021 |
| FY2019 | Dec 31, 2018 | 0 | Mar 26, 2020 |
| FY2018 | Dec 31, 2017 | 0 | Apr 12, 2019 |
| FY2017 | Dec 31, 2016 | 0 | Mar 21, 2018 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 25.96M | Mar 18, 2026 |
| FY2025 | Dec 31, 2024 | 26.00M | Mar 18, 2026 |
| FY2024 | Dec 31, 2023 | 26.51M | Mar 26, 2025 |
| FY2023 | Dec 31, 2022 | 26.92M | Mar 21, 2024 |
| FY2022 | Dec 31, 2021 | 26.92M | Mar 16, 2023 |
| FY2022 | Dec 31, 2020 | 26.92M | Mar 16, 2022 |
| FY2020 | Dec 31, 2019 | 26.92M | Mar 26, 2021 |
| FY2019 | Dec 31, 2018 | 26.92M | Mar 26, 2020 |
| FY2018 | Dec 31, 2017 | 26.92M | Apr 12, 2019 |
| FY2017 | Dec 31, 2016 | 26.91M | Mar 21, 2018 |